Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

AT&T Stock: Bull vs. Bear


In the financial coliseum of 2023, we find AT (NYSE: T) and its investors locked in a high-stakes bull-versus-bear duel. The telecom giant, a perennial darling for dividend-seekers, has found itself in a precarious wobble. Its stock price has slipped a brutal 20% lower this year, missing out on the S 500 gaining 17% in the same period. This imbalance was sparked by AT's first-quarter earnings report, where adequate revenues and earnings were overshadowed by disappointingly weak cash flows.

Now, as the economy gradually shakes off the chill of the 2022 inflation crisis, investors are left with a conundrum: Is AT a discounted gem ready to shine or a financial house of cards under catastrophic pressure?

Two tech experts from The Motley Fool are stepping into the ring to settle the score. They are about to guide you through the highs and lows of AT's year, presenting both the bull and bear perspectives.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,047 €
-1,05 %
Allergy Therapeutics PLC muss heute Verluste wegstecken. Die Aktie notiert im Vergleich zu gestern um -1,05 % tiefer.

Like: 0
T
Teilen

Kommentare